Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Joyce V Lee^#^{1

2}, Filomena Housley^#^{1

2}, Christina Yau^{3

4}, Rachel Nakagawa^{1

2}, Juliane Winkler^{1

2}, Johanna M Anttila⁵, Pauliina M Munne⁵, Mariel Savelius⁵, Kathleen E Houlahan⁶, Daniel Van de Mark^{1

2}, Golzar Hemmati^{1

2}, Grace A Hernandez^{1

2}, Yibing Zhang^{1

2}, Susan Samson^{2

7}, Carole Baas⁸, Marleen Kok^{9

10}, Laura J Esserman^{2

11

12}, Laura J van 't Veer^{2

4}, Hope S Rugo^{2

13}, Christina Curtis^{6

14

15}, Juha Klefström⁵, Mehrdad Matloubian¹⁶, Andrei Goga^{17

18

19}

Affiliations

¹ Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
² Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
³ Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.
⁴ Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA.
⁵ Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
⁶ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
⁷ Breast Science Advocacy Core, UCSF Breast Oncology Program, San Francisco, California, USA.
⁸ Alamo Breast Cancer Foundation, San Antonio, Texas, USA.
⁹ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁰ Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹¹ Department of Surgery, University of California, San Francisco, California, USA.
¹² Department of Radiology, University of California, San Francisco, California, USA.
¹³ Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA.
¹⁴ Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
¹⁵ Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
¹⁶ Department of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, California, USA. mehrdad.matloubian@ucsf.edu.
¹⁷ Department of Cell and Tissue Biology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
¹⁸ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
¹⁹ Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.

^# Contributed equally.

PMID: 36414627
PMCID: PMC9681724
DOI: 10.1038/s41467-022-34570-5

Published Erratum

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Joyce V Lee et al. Nat Commun. 2022.

. 2022 Nov 21;13(1):7140.

doi: 10.1038/s41467-022-34570-5.

Authors

Affiliations

¹ Department of Cell and Tissue Biology, University of California, San Francisco, California, USA.
² Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
³ Cancer and Developmental Therapeutics Program, Buck Institute for Research on Aging, Novato, California, USA.
⁴ Departments of Pathology and Laboratory Medicine, University of California, San Francisco, California, USA.
⁵ Finnish Cancer Institute, FICAN South Helsinki University Hospital & Translational Cancer Medicine, Medical Faculty, University of Helsinki, Helsinki, Finland.
⁶ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
⁷ Breast Science Advocacy Core, UCSF Breast Oncology Program, San Francisco, California, USA.
⁸ Alamo Breast Cancer Foundation, San Antonio, Texas, USA.
⁹ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁰ Department of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹¹ Department of Surgery, University of California, San Francisco, California, USA.
¹² Department of Radiology, University of California, San Francisco, California, USA.
¹³ Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA.
¹⁴ Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.
¹⁵ Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
¹⁶ Department of Medicine, Division of Rheumatology and Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, California, USA. mehrdad.matloubian@ucsf.edu.
¹⁷ Department of Cell and Tissue Biology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
¹⁸ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.
¹⁹ Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, California, USA. andrei.goga@ucsf.edu.

^# Contributed equally.

PMID: 36414627
PMCID: PMC9681724
DOI: 10.1038/s41467-022-34570-5

No abstract available

PubMed Disclaimer

Erratum for

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.
Lee JV, Housley F, Yau C, Nakagawa R, Winkler J, Anttila JM, Munne PM, Savelius M, Houlahan KE, Van de Mark D, Hemmati G, Hernandez GA, Zhang Y, Samson S, Baas C, Kok M, Esserman LJ, van 't Veer LJ, Rugo HS, Curtis C, Klefström J, Matloubian M, Goga A. Lee JV, et al. Nat Commun. 2022 Jun 27;13(1):3671. doi: 10.1038/s41467-022-31238-y. Nat Commun. 2022. PMID: 35760778 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Affiliations

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources